Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Baculovirus virion completely eliminates liver-stage parasites in mouse model

Baculovirus virion completely eliminates liver-stage parasites in mouse model

Protecting powerhouse of cells could provide better way to treat acute kidney injury

Protecting powerhouse of cells could provide better way to treat acute kidney injury

App that could detect level of anemia by looking at fingernails

App that could detect level of anemia by looking at fingernails

Advances in gene therapy for inherited blood disorders

Advances in gene therapy for inherited blood disorders

Russian researchers develop novel combined action drug for cancer diagnostics and treatment

Russian researchers develop novel combined action drug for cancer diagnostics and treatment

New gene therapy treatment for Sickle Cell Anemia reverses symptoms in adults

New gene therapy treatment for Sickle Cell Anemia reverses symptoms in adults

Study examines whether taking multiple medications for heart failure can limit abilities in older adults

Study examines whether taking multiple medications for heart failure can limit abilities in older adults

Daily hydroxyurea treatment may bring some relief for African children with sickle cell anemia

Daily hydroxyurea treatment may bring some relief for African children with sickle cell anemia

Johns Hopkins researchers report challenges in treating severe crisis pain of sickle cell disease

Johns Hopkins researchers report challenges in treating severe crisis pain of sickle cell disease

FDA approves new treatment for AML patients

FDA approves new treatment for AML patients

New first-line treatment for peripheral T-cell lymphoma approved by FDA

New first-line treatment for peripheral T-cell lymphoma approved by FDA

New oral drug reduces menstrual bleeding for women with common uterine tumors

New oral drug reduces menstrual bleeding for women with common uterine tumors

Study identifies novel missense mutation affecting YARS causes multisystem disease

Study identifies novel missense mutation affecting YARS causes multisystem disease

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Researchers discover biomarker for most common type of heart failure

Researchers discover biomarker for most common type of heart failure

High-impact clinical trial results could affect kidney-related medical care

High-impact clinical trial results could affect kidney-related medical care

Better blood pressure control may prevent organ damage related to hypertensive emergencies in diabetics

Better blood pressure control may prevent organ damage related to hypertensive emergencies in diabetics

EKF introduces new hand-held lactate analyzer for rapid sports performance monitoring

EKF introduces new hand-held lactate analyzer for rapid sports performance monitoring

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma